Back to LYEL

GEODE CAPITAL MANAGEMENT, LLC → LYEL

GEODE CAPITAL MANAGEMENT, LLC LYEL Position History

Lyell Immunopharma, Inc. • Healthcare

Quarters held
10
Latest value
$386K
Q3 2026
Peak value
$4.1M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$1.7M
Q3 2025$380K
Q4 2025$4.1M
Q4 2025$952K
Q1 2026$2.7M
Q1 2026$642K
Q2 2026$3.7M
Q2 2026$653K
Q3 2026$2.3M
Q3 2026$386K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$386K39.4K——
Q3 2026$2.3M235.2K——
Q2 2026$653K46.5K——
Q2 2026$3.7M264.2K——
Q1 2026$642K32.0K——
Q1 2026$2.7M135.0K——
Q4 2025$952K30.9K——
Q4 2025$4.1M132.1K——
Q3 2025$380K23.4K——
Q3 2025$1.7M106.9K——

Other funds holding LYEL

Other GEODE CAPITAL MANAGEMENT, LLC positions

NVDA

NVIDIA CORP

$122B
AAPL

APPLE INC

$108.8B
NVDA

NVIDIA CORP

$105.6B
NVDA

NVIDIA CORP

$96.7B
NVDA

NVIDIA CORP

$96.6B
AAPL

APPLE INC

$93.5B
NVDA

NVIDIA CORP

$91.6B
MSFT

MICROSOFT CORP

$86B